Raising Funds for AI in Healthcare
Spanish startup Quibim has raised $50 million in a Series A funding round to further develop its AI models for medical imaging, focusing on oncology, immunology, neurology, and metabolic disorders. The company is using AI to enhance diagnostic accuracy through visual data from X-rays, CT scans, and MRIs.

Innovative Solutions in Disease Detection
Quibim's flagship product, QP-Prostate, is aimed at improving prostate cancer detection, with plans for similar products for the brain, liver, breast, and lungs. Additionally, QP-Insights is designed for processing multi-omics data, supporting clinical trials and related studies.

Long-Term Vision for Digital Twins
The company aims to create digital twins of the human body to develop dynamic models for a better understanding of human health. The current focus is on organ and lesion-level data, exemplified by the QP-Prostate model.

U.S. Expansion Plans
With over $70 million raised since its inception, Quibim plans to expand into the U.S., having already received FDA clearance for QP-Prostate and hired a chief medical officer in the country. The company is collaborating with prominent institutions like Stanford University and Mass General Brigham, and Philips is integrating Quibim’s AI models into its scanners.

Strong Investor Support
The Series A round was led by Spanish venture capital firm Asabys, along with Buenavista, Amadeus Capital Partners, and others, including Tony Fadell, co-creator of the iPod and iPhone.

Mission for Precision Health
CEO Ángel Alberich-Bayarri emphasized Quibim’s mission to leverage imaging for precision health, aiming to revolutionize diagnostics and improve patient outcomes as part of their global expansion.